CP‐101,606: An NR2B‐Selective NMDA Receptor Antagonist

This publication has 62 references indexed in Scilit:

• Effect of CP101,606, a Novel NR2B Subunit Antagonist of theN-Methyl-d-Aspartate Receptor, on the Volume of Ischemic Brain Damage and Cytotoxic Brain Edema After Middle Cerebral Artery Occlusion in the Feline Brain
  Stroke, 1997
• Massive Persistent Release of Excitatory Amino Acids Following Human Occlusive Stroke
  Stroke, 1995
• NMDA receptor-dependent and -independent immediate early gene expression induced by focal mechanical brain injury
  Neurochemistry International, 1995
• Clinical Experience With Excitatory Amino Acid Antagonist Drugs
  Stroke, 1995
• Calcium‐Mediated Processes in Neuronal Degeneration^a
  Annals of the New York Academy of Sciences, 1994
• NMDA Antagonist Neurotoxicity: Mechanism and Prevention
  Science, 1991
• Cerebrovascular Changes in a Rat Model of Moderate Closed-Head Injury
  Journal of Neurotrauma, 1991
• Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex
  Neuroscience Letters, 1989
• Glutamate dysfunction in Alzheimer's disease: an hypothesis
  Trends in Neurosciences, 1987
• Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.
  Stroke, 1986